TRS tops consensus in 2Q 2025 and increases full-year 2025E guidance; strategic review remains on going under new leadership; fair value increases to $35.50 per share (from $32 per share)
Today, before the market open, TRS reported 2Q 2025 consolidated sales up ~14% to $274.8 million (compared with consensus of $251.3 million), as organic growth of ~8% and ~24% at the Packaging & Aerospace segments more than offset a 7%% decline at Specialty Products (including the Arrow Engine divestiture). Adj. EBITDA rose ~31% to $47.9 million (versus consensus of ~$40.77 million) while adj. EPS rose ~42% to $0.61 (compared with consensus of $0.47). Adj. free cash flow (FCF) was $16.9 million during the quarter (versus $11.4 million in the prior year period).
TRS ended 2Q 2025, with net debt of $394.4 million, including $30.3 million of cash & debt of ~$394.3 million, and a net leverage ratio of 2.4x (compared to 2.6x at year-end 2024 and its 4.0x covenant) with no significant maturities until 2029.
In terms of capital allocation, the company has repurchased 106,200 shares for ~$2.3 million in the first-six months of 2025 (at an implied purchase price of ~$21.65 per share). The company remains authorized to repurchase an additional ~$65.4 million worth of shares.
On the guidance front, in conjunction with 2Q 2025 results TRS increased its consolidated full-year 2025E guidance, which now calls for consolidated sales growth of 8%-10% (up from 4%-6%) and adj. EPS of $1.95-$2.00 (up from $1.70-$1.85 and compares with current consensus of $1.63; see Exhibit 1 on page 2).
By segment, management anecdotally forecasts top-line growth of “GDP-plus” and “~20%” (organic) at Packaging & Aerospace, respectively. Adj. EBITDA margins are expected to “expand slightly” at Packaging and improve ~400 bps year-over-year at Aerospace. Specialty Product segment sales, which are currently comprised of the Norris Cylinders business following the Arrow Engine divestiture in January 2025, are projected to grow in the “mid-single digits” with margins remaining roughly “flat to slightly up” year-over-year.
On this morning’s conference call, newly appointed CEO (as of June 2025), Thomas Snyder, formerly of Silgan Holdings (NYSE: SLGN), indicated that the previously announced portfolio review remains on-going (although the immediate focus remains on driving operational improvements).
Our base case fair value estimate for TRS increases to $35.50 per share (from $32 per share), reflecting a blended multiple of ~9.5x on 2026E adj. EBITDA of ~$188 million, projected net debt of ~$338 million and a fully diluted share count of ~40.1 million (see Exhibit #2 on page 2).
PCS Research Group welcomes and encourages your feedback. Please feel free to call us if we can be of service.